3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
10
Thoracic
2
Other hematologic neoplasm
2
Gynecologic
2
Genitourinary
2
Endocrine
2
Plasma cell
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
3102
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2086
Leukemia
2013
Leukemia, Lymphocytic, Chronic, B-Cell
1771
Myelodysplastic Syndromes
1298
Hematologic Neoplasms
1067
Lymphoma
1029
Lymphoma, Non-Hodgkin
981
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
713
Lymphoma, Follicular
704
Lymphoma, Mantle-Cell
678
Lymphoma, Large B-Cell, Diffuse
657
Burkitt Lymphoma
642
Multiple Myeloma
639
Lymphoma, B-Cell, Marginal Zone
599
Recurrence
587
Hodgkin Disease
575
Leukemia, Myelomonocytic, Chronic
495
Lymphoma, Large-Cell, Immunoblastic
419
Neoplasms
402
Myeloproliferative Disorders
402
Leukemia, Myeloid, Chronic-Phase
391
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
382
Congenital Abnormalities
357
Waldenstrom Macroglobulinemia
330
Blast Crisis
324
Leukemia, Myeloid, Accelerated Phase
290
Lymphoma, T-Cell, Cutaneous
280
Primary Myelofibrosis
270
Anemia, Refractory, with Excess of Blasts
251
Interventions
Therapeutics
1
Geriatric Assessment
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Treatment Adherence and Compliance
×
Other hematologic neoplasm
×
Clear all
NCT05260203
2024-11-06
MargheRITA
Advice Pharma Group srl
Phase NA
Completed
124 enrolled
NCT06373471
2024-04-18
IMPROVE
Odense University Hospital
Phase NA
Recruiting
152 enrolled